Event

OSCO Presents ASCO Direct ™

OSCO invites you to attend our 2022 In-Person Fall Conference, which will be an officially licensed ASCO Direct ™ event.   This conference will highlight the foremost research and strategies in oncology that were presented by speakers at the 2022 American Society of Clinical Oncology’s (ASCO®) Annual Meeting and other top meetings this year.   This conference is designed to update the educational needs of Hematologists/Oncologists, Nurses, Pharmacists, Physician Assistants and other health care professionals specializing in oncology.

This activity will be approved for continuing education credits for physicians and nurses.  There is no fee for this conference, but registration is required.

  • ASCO Direct ™ is an officially licensed program of the American Society of Clinical Oncology (ASCO®).
  • This conference is jointly provided by Postgraduate Institute for Medicine and Oklahoma Society of Clinical Oncology, Inc.
  • This activity has been approved for a maximum of 4.0 AMA PRA Category 1 Credit(s)™and 4.0 ANCC contact hours for Registered Nurses.

Pharmaceutical Companies interested in Corporate Membership? Join here →

Companies interested in a virtual exhibit for Fall Conference? Purchase here →

Show Agenda
  • 7:00 AM (CST)
    Virtual Exhibitor Booths Set-up
  • 7:30 AM (CST)
    Continental Breakfast
  • 8:00 AM - 8:15 AM (CST)
    Welcome Remarks & Annual Member Meeting
    Jose Eugenio Najera, MD

    Jose Eugenio Najera, MD

    OSCO President

  • 8:15 AM - 9:15 AM (CST)
    Update on GE, Hepatobiliary and Pancreatic Cancers
    Rutika Mehta, MD, MPH

    Rutika Mehta, MD, MPH

    Medical Oncology Specialist

    Moffitt Cancer Center, Tampa, FL

  • 9:15 AM - 10:15 AM (CST)
    Update on Neuro-Oncology
    Aaron Mammoser, MD

    Aaron Mammoser, MD

    Department of Neurosurgery

    LSU Health New Orleans School of Medicine, LA

  • 10:15 AM - 10:45 AM (CST)
    Break for Exhibits/Refreshments
  • 10:45 AM-11:45 AM (CST)
    Update on Gynecologic Oncology
    Kathleen N. Moore, MD, MS

    Kathleen N. Moore, MD, MS

    Associate Director of Clinical Research Director, Oklahoma TSET Phase I Program

    Stephenson Cancer Center, Oklahoma City, OK

  • 11:45 AM - 12:45 PM (CST)
    Update on NSCLC
    Joshua Sabari, MD

    Joshua Sabari, MD

    Assistant Professor, Dept. of Medicine

    NYU Langone Health, New York, NY

  • 12:45 PM (CST)
    Adjournment